With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Filter the global stock universe by sector, market cap, P/E, ROE, dividend yield, and more. Covered tickers show our latest rating, fair value, and upside; data-only tickers still get profile, valuation, profitability, growth, ownership, and market indicators. For curated editorial screens (wide-moat, dividend aristocrats, etc.), see stock lists.
| Data only |
| HRMY | Harmony Biosciences Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 35.86 | 2.1B | 14.5x | +17.9% | +0.3% | Data only |
| ZLAB | Zai Lab Limited Biotechnology | US / NASDAQ | Healthcare | USD 18.31 | 2.1B | n/a | -24.2% | -52.7% | Data only |
| NEOG | Neogen Corporation Medical Devices | US / NASDAQ | Healthcare | USD 9.40 | 2B | n/a | -25.6% | +73.4% | Data only |
| PVLA | Palvella Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 143 | 2B | n/a | -34.2% | +257.7% | Data only |
| IOVA | Iovance Biotherapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 4.56 | 2B | n/a | -47.5% | +54.6% | Data only |
| SION | Sionna Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 44.81 | 2B | n/a | -26.7% | +125.7% | Data only |
| ADMA | ADMA Biologics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 8.71 | 2B | 12.8x | +43.3% | -51.6% | Data only |
| NEO | NeoGenomics, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | USD 15.27 | 2B | n/a | -6.3% | +136.4% | Data only |
| SLS | SELLAS Life Sciences Group, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 10.10 | 2B | n/a | -43.6% | +467.4% | Data only |
| HCM | HUTCHMED (China) Limited Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | USD 11.39 | 2B | 4.3x | +45.3% | -36.7% | Data only |
| UFPT | UFP Technologies, Inc. Medical Devices | US / NASDAQ | Healthcare | USD 255 | 2B | 29.1x | +17.2% | +4.2% | Data only |
| URGN | UroGen Pharma Ltd. Biotechnology | US / NASDAQ | Healthcare | USD 40.45 | 2B | n/a | n/a | +114.0% | Data only |
| ZBIO | Zenas BioPharma, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 31.09 | 2B | n/a | -137.1% | +89.0% | Data only |
| RAPP | Rapport Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 40.94 | 2B | n/a | -28.3% | +144.6% | Data only |
| AUPH | Aurinia Pharmaceuticals Inc. Biotechnology | US / NASDAQ | Healthcare | USD 15.18 | 2B | 7.0x | +65.0% | +70.8% | Data only |
| PGEN | Precigen, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 5.45 | 1.9B | n/a | -1145.4% | +244.9% | Data only |
| FTRE | Fortrea Holdings Inc. Biotechnology | US / NASDAQ | Healthcare | USD 20.40 | 1.9B | n/a | -15.3% | +196.9% | Data only |
| GHRS | GH Research PLC Biotechnology | US / NASDAQ | Healthcare | USD 27.98 | 1.9B | n/a | -19.7% | +86.8% | Data only |
| NBTX | Nanobiotix S.A. Biotechnology | US / NASDAQ | Healthcare | USD 37.85 | 1.9B | n/a | n/a | +469.6% | Data only |
| WGS | GeneDx Holdings Corp. Diagnostics & Research | US / NASDAQ | Healthcare | USD 63.69 | 1.9B | n/a | -30.4% | -25.0% | Data only |
| OMCL | Omnicell, Inc. Health Information Services | US / NASDAQ | Healthcare | USD 41.40 | 1.9B | 94.1x | +1.6% | +42.8% | Data only |
| FBRX | Forte Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 76.53 | 1.9B | n/a | -188.4% | +558.0% | Data only |
| TYRA | Tyra Biosciences, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 31.11 | 1.9B | n/a | -36.9% | +180.0% | Data only |
| LKFT | Lakefront Biotherapeutics NV Biotechnology | US / NASDAQ | Healthcare | USD 27.72 | 1.8B | 3.3x | +16.3% | -15.7% | Data only |
| MESO | Mesoblast Limited Biotechnology | US / NASDAQ | Healthcare | USD 14.13 | 1.8B | n/a | -18.2% | -11.3% | Data only |
| STOK | Stoke Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 29.48 | 1.8B | n/a | -45.6% | +130.1% | Data only |
| OCUL | Ocular Therapeutix, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 8.36 | 1.8B | n/a | -68.6% | -30.8% | Data only |
| CDNA | CareDx, Inc. Diagnostics & Research | US / NASDAQ | Healthcare | USD 35.41 | 1.8B | n/a | -2.4% | +176.9% | Data only |
| GLUE | Monte Rosa Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 21.56 | 1.8B | n/a | -32.6% | +288.5% | Data only |
| TSHA | Taysha Gene Therapies, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 5.61 | 1.8B | n/a | -97.3% | +110.1% | Data only |
| NVCR | NovoCure Limited Medical Devices | US / NASDAQ | Healthcare | USD 15.20 | 1.8B | n/a | -43.2% | +30.6% | Data only |
| KARD | Kardigan, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 19.73 | 1.8B | n/a | n/a | n/a | Data only |
| DMRA | Damora Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 28.33 | 1.7B | n/a | -89.5% | +651.5% | Data only |
| ANIP | ANI Pharmaceuticals, Inc. Drug Manufacturers - Specialty & Generic | US / NASDAQ | Healthcare | USD 81.78 | 1.7B | 21.0x | +18.3% | +23.0% | Data only |
| SNDX | Syndax Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 19.22 | 1.7B | n/a | -189.5% | +100.8% | Data only |
| MRVI | Maravai LifeSciences Holdings, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 6.59 | 1.7B | n/a | -41.0% | +148.7% | Data only |
| BCAX | Bicara Therapeutics Inc. Biotechnology | US / NASDAQ | Healthcare | USD 25.89 | 1.7B | n/a | -32.3% | +119.2% | Data only |
| IMCR | Immunocore Holdings plc Biotechnology | US / NASDAQ | Healthcare | USD 33.42 | 1.7B | n/a | -7.1% | -1.5% | Data only |
| ALMR | Alamar Biosciences, Inc. Medical Devices | US / NASDAQ | Healthcare | USD 24.37 | 1.7B | n/a | n/a | n/a | Data only |
| GENB | Generate Biomedicines, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 13.08 | 1.7B | n/a | n/a | n/a | Data only |
| AAPG | Ascentage Pharma Group International Biotechnology | US / NASDAQ | Healthcare | USD 18.31 | 1.7B | n/a | -154.6% | -53.4% | Data only |
| ABCL | AbCellera Biologics Inc. Biotechnology | US / NASDAQ | Healthcare | USD 5.39 | 1.6B | n/a | -14.7% | +9.6% | Data only |
| ASTH | Astrana Health, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | USD 36.51 | 1.6B | 60.0x | +5.7% | +54.4% | Data only |
| SRPT | Sarepta Therapeutics, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 15.54 | 1.6B | 24.4x | +4.9% | +12.1% | Data only |
| HCSG | Healthcare Services Group, Inc. Medical Care Facilities | US / NASDAQ | Healthcare | USD 23.43 | 1.6B | 13.6x | +24.7% | +76.8% | Data only |
| INVA | Innoviva, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 21.64 | 1.6B | 3.8x | +50.7% | +16.7% | Data only |
| RXRX | Recursion Pharmaceuticals, Inc. Biotechnology | US / NASDAQ | Healthcare | USD 2.97 | 1.6B | n/a | -57.2% | -52.9% | Data only |
| ZYME | Zymeworks Inc. Biotechnology | US / NASDAQ | Healthcare | USD 22.01 | 1.6B | n/a | -42.0% | +63.5% | Data only |
| INNV | InnovAge Holding Corp. Medical Care Facilities | US / NASDAQ | Healthcare | USD 11.47 | 1.6B | n/a | -5.9% | +205.9% | Data only |
